Glanbia Nutritionals named exclusive representative of Ajinomoto’s CapsiAtra in the US

By Stephen DANIELLS

- Last updated on GMT

Glanbia Nutritionals named exclusive representative of Ajinomoto’s CapsiAtra in the US
Ajinomoto Co., Inc, has named Glanbia Nutritionals (NA), Inc., as the exclusive distributor of its CapsiAtra product for targeted markets in the US.

The companies will work closely to introduce CapsiAtra into innovative and novel applications, with the target sectors identified as weight management products and sports nutrition.    

The ingredient is described as a dihydrocapsiate compound naturally found in CH-19 Sweet peppers that holds clinical benefits in weight management, endurance and metabolism. It can be used in ready-to-mix, capsule and tablet applications. In addition to numerous human clinical trials, the ingredient has also received a letter of no objection from the FDA in regards to its GRAS safety dossier.

“As an innovative ingredient with impressive scientific support, CapsiAtra will be an excellent addition to our product line,”​ said Kevin Meyer, Vice President of Sales and Business Development for Glanbia Nutritionals.

“We are very pleased with our strategic partnership with Glanbia Nutritionals in terms of one of our most valuable specialty ingredients: CapsiAtra,”​ said Tak Kuwashima, General Manager of Ajinomoto Co., Inc. “Glanbia’s nutritional expertise and sales team will open doors for CapsiAtra and allow us to enter into new and innovative markets that have been longing for scientifically proven ingredients in terms of both safety and efficacy.”

 

Related news

Related products

show more

Natural, slow-release caffeine by Lipofoods

Natural, slow-release caffeine by Lipofoods

Lipofoods, a Lubrizol Company | 25-Sep-2017 | Data Sheet

Lipofoods presents NEWCAFF™ microcapsules, a natural, slow-release caffeine with a clean non-bitter taste, ideal for sports and nutrition products targeting...

Transparency and Dietary Supplement Quality

Transparency and Dietary Supplement Quality

Gemini Pharmaceuticals | 18-Sep-2017 | Technical / White Paper

A Brand Owner is 100% responsible for the quality of their products - not the Contract Manufacturing Organization (CMO). This is exactly why Gemini Pharmaceuticals developed...

Related suppliers

Follow us

Products

View more

Webinars